107 related articles for article (PubMed ID: 23140648)
1. Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy.
Cohen D; Bogers JP; van Dijk D; Bakker B; Schulte PF
J Clin Psychiatry; 2012 Oct; 73(10):1307-12. PubMed ID: 23140648
[TBL] [Abstract][Full Text] [Related]
2. Can Slow Personalized Titration Using C-Reactive Protein Monitoring Decrease the High Rates and Mortality of Clozapine-Associated Myocarditis Seen in Some Countries? A Call for Research.
de Leon J
J Clin Psychopharmacol; 2024 May-Jun 01; 44(3):212-219. PubMed ID: 38595145
[TBL] [Abstract][Full Text] [Related]
3. The physical health and side-effect monitoring of patients prescribed clozapine: data from a clinical audit conducted in UK mental health services.
Barnes TRE; MacCabe JH; Kane JM; Delgado O; Paton C
Ther Adv Psychopharmacol; 2020; 10():2045125320937908. PubMed ID: 32821377
[TBL] [Abstract][Full Text] [Related]
4. Management of clozapine treatment during the COVID-19 pandemic.
Gee S; Gaughran F; MacCabe J; Shergill S; Whiskey E; Taylor D
Ther Adv Psychopharmacol; 2020; 10():2045125320928167. PubMed ID: 32542111
[TBL] [Abstract][Full Text] [Related]
5. Clozapine-Related Functional Bowel Obstruction: A Rare Adverse Effect Unmasking Quetiapine and Benztropine Interaction Raising Need for Bowel Surveillance.
Tiwari A; Kambhatla S; George N; Anumolu P; Malik N; Kambhatla S
ACG Case Rep J; 2024 May; 11(5):e01351. PubMed ID: 38764552
[TBL] [Abstract][Full Text] [Related]
6. Life-threatening haematemesis associated with clozapine: a case report and literature review.
Adebayo KO; Ibrahim N; Mosanya T; Eegunranti B; Suleiman B; Ayankunle A
Ther Adv Psychopharmacol; 2013 Oct; 3(5):275-7. PubMed ID: 24167703
[TBL] [Abstract][Full Text] [Related]
7. Clozapine clinical toolkit optimizes inpatient clozapine monitoring.
Gessner B; Carter M; Rahnama K; Almeida A; Borralho C; Mihic T; Ng JCY; Puyat JH; Russolillo A; Halpape KC
Ment Health Clin; 2024 Apr; 14(2):85-91. PubMed ID: 38694883
[TBL] [Abstract][Full Text] [Related]
8. Time for a change to clozapine haematological monitoring.
Cheng A; Buten S; Large M
Australas Psychiatry; 2024 May; ():10398562241258764. PubMed ID: 38820548
[TBL] [Abstract][Full Text] [Related]
9. Clozapine in primary care.
Winckel K; Siskind D
Aust Prescr; 2017 Dec; 40(6):231-236. PubMed ID: 29375185
[No Abstract] [Full Text] [Related]
10. Use of Erythromycin in Clozapine Induced Constipation: A Case Report.
Yadav S; Das S; Takács A; Pantelis C; Thomas N
Indian J Psychol Med; 2024 May; 46(3):281-282. PubMed ID: 38699766
[No Abstract] [Full Text] [Related]
11. Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug.
Dell'Osso L; Bonelli C; Nardi B; Giovannoni F; Pronestì C; Cremone IM; Amatori G; Pini S; Carpita B
Brain Sci; 2024 Jan; 14(1):. PubMed ID: 38275523
[TBL] [Abstract][Full Text] [Related]
12. Evaluating Monitoring Guidelines of Clozapine-Induced Adverse Effects: a Systematic Review.
Smessaert S; Detraux J; Desplenter F; De Hert M
CNS Drugs; 2024 Feb; 38(2):105-123. PubMed ID: 38236524
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with the initiation of laxative use in the same patients with schizophrenia over a 20-year period: Retrospective cohort study.
Kawamata Y; Sugawara N; Sasaki T; Yokoyama S; Okayasu H; Shinozaki M; Takeuchi Y; Sato A; Ishikawa T; Komahashi-Sasaki H; Miyazaki K; Fukasawa T; Furukori H; Yasui-Furukori N
Neuropsychopharmacol Rep; 2024 Mar; 44(1):60-66. PubMed ID: 37698084
[TBL] [Abstract][Full Text] [Related]
14. [Safety aspects during treatment with clozapine. : Monitoring and rechallenge - a narrative review].
Berger SJ; Hofer A
Neuropsychiatr; 2023 Sep; 37(3):130-135. PubMed ID: 37389803
[TBL] [Abstract][Full Text] [Related]
15. Reflections on the Lack of Consideration of Ethnic Ancestry to Stratify Clozapine Dosing.
de Leon J
Psychiatry Investig; 2023 Mar; 20(3):183-195. PubMed ID: 36850057
[TBL] [Abstract][Full Text] [Related]
16. Lethal Acute Colonic Pseudo-Obstruction in a Patient Using a Combination of Olanzapine and Clozapine.
Bouhuis RH; van Verschuer VMT; Zaal RJ; Dieleman S
J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):511-513. PubMed ID: 35916591
[No Abstract] [Full Text] [Related]
17. A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia.
Correll CU; Agid O; Crespo-Facorro B; de Bartolomeis A; Fagiolini A; Seppälä N; Howes OD
CNS Drugs; 2022 Jul; 36(7):659-679. PubMed ID: 35759211
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic-Induced Constipation: A Review of the Pathogenesis, Clinical Diagnosis, and Treatment.
Xu Y; Amdanee N; Zhang X
CNS Drugs; 2021 Dec; 35(12):1265-1274. PubMed ID: 34427901
[TBL] [Abstract][Full Text] [Related]
19. Clozapine-associated neutropenia following augmentation with sodium valproate.
Jakobsen MI; Grønborg H; Hansen HV; Fink-Jensen A
SAGE Open Med Case Rep; 2021; 9():2050313X211019791. PubMed ID: 34104448
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
